找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Chemokines; Chemokines and Their Nuska Tschammer Book 2015 Springer International Publishing Switzerland 2015 Allosteric Modulation.CXCR3 T

[復(fù)制鏈接]
樓主: 從未沮喪
11#
發(fā)表于 2025-3-23 10:06:07 | 只看該作者
Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview,ory processes fueled the use of CCR5 antagonists for the treatment of rheumatoid arthritis. Unfortunately, the use of maraviroc for the treatment of rheumatoid arthritis failed due to its inefficacy. Some of the ligands, e.g., TAK-779 and TAK-652, were also found to be dual antagonists of CCR2 and C
12#
發(fā)表于 2025-3-23 14:58:38 | 只看該作者
Book 2015roughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known
13#
發(fā)表于 2025-3-23 20:16:06 | 只看該作者
Werner Dickmeis,Rolf Joachim Nesselpact of structures on rational molecular design initiatives. As an inherently challenging family of GPCRs, chemokine receptors may only reveal their secrets when tackled by the efficient symbiosis of computational approaches with experimental structure determination.
14#
發(fā)表于 2025-3-24 01:26:00 | 只看該作者
https://doi.org/10.1007/978-3-322-87917-2ory processes fueled the use of CCR5 antagonists for the treatment of rheumatoid arthritis. Unfortunately, the use of maraviroc for the treatment of rheumatoid arthritis failed due to its inefficacy. Some of the ligands, e.g., TAK-779 and TAK-652, were also found to be dual antagonists of CCR2 and C
15#
發(fā)表于 2025-3-24 06:20:34 | 只看該作者
16#
發(fā)表于 2025-3-24 06:57:59 | 只看該作者
17#
發(fā)表于 2025-3-24 11:15:28 | 只看該作者
Chemokine Receptors in Allergy, Inflammation, and Infectious Disease,coupled receptors, which represent one of the most druggable classes of proteins. In this review we will examine the role of chemokines in autoimmunity and inflammation by concentrating on the part they play in the pathophysiology of several diseases including asthma, multiple sclerosis, and rheumat
18#
發(fā)表于 2025-3-24 16:27:16 | 只看該作者
19#
發(fā)表于 2025-3-24 22:16:20 | 只看該作者
20#
發(fā)表于 2025-3-25 00:54:44 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 23:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
蕲春县| 巴楚县| 沂源县| 务川| 交口县| 六盘水市| 阳信县| 石城县| 江油市| 晋州市| 大竹县| 天门市| 姚安县| 额尔古纳市| 河津市| 体育| 林芝县| 彭州市| 天柱县| 武乡县| 青岛市| 富蕴县| 东安县| 宜春市| 宜都市| 涟源市| 汉源县| 江山市| 饶阳县| 扎赉特旗| 南漳县| 安达市| 涟水县| 宜春市| 泸水县| 泉州市| 于都县| 汉阴县| 肇庆市| 大余县| 德江县|